A detailed history of Doheny Asset Management /Ca transactions in Johnson & Johnson stock. As of the latest transaction made, Doheny Asset Management /Ca holds 8,399 shares of JNJ stock, worth $1.22 Million. This represents 0.93% of its overall portfolio holdings.

Number of Shares
8,399
Previous 9,022 6.91%
Holding current value
$1.22 Million
Previous $1.32 Million 3.18%
% of portfolio
0.93%
Previous 0.94%

Shares

26 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$145.48 - $167.38 $90,634 - $104,277
-623 Reduced 6.91%
8,399 $1.36 Million
Q2 2024

Aug 15, 2024

SELL
$144.38 - $157.78 $1.05 Million - $1.15 Million
-7,305 Reduced 44.74%
9,022 $1.32 Million
Q2 2024

Aug 07, 2024

BUY
$144.38 - $157.78 $929,374 - $1.02 Million
6,437 Added 65.09%
16,327 $2.39 Million
Q1 2024

May 08, 2024

SELL
$155.22 - $162.74 $31,044 - $32,548
-200 Reduced 1.98%
9,890 $1.56 Million
Q4 2023

Feb 06, 2024

SELL
$145.6 - $158.88 $289,307 - $315,694
-1,987 Reduced 16.45%
10,090 $1.58 Million
Q3 2023

Nov 08, 2023

SELL
$155.75 - $174.48 $215,869 - $241,829
-1,386 Reduced 10.29%
12,077 $1.88 Million
Q1 2023

May 16, 2023

BUY
$151.05 - $180.26 $260,561 - $310,948
1,725 Added 14.7%
13,463 $2.09 Million
Q4 2022

Feb 14, 2023

SELL
$160.2 - $179.79 $276,345 - $310,137
-1,725 Reduced 12.81%
11,738 $2.07 Million
Q3 2022

Nov 10, 2022

SELL
$161.33 - $179.52 $137,130 - $152,592
-850 Reduced 5.94%
13,463 $2.2 Million
Q1 2022

May 16, 2022

SELL
$158.14 - $179.59 $15,813 - $17,959
-100 Reduced 0.69%
14,313 $2.54 Million
Q4 2021

Feb 15, 2022

SELL
$155.93 - $173.01 $57,694 - $64,013
-370 Reduced 2.5%
14,413 $2.47 Million
Q3 2021

Oct 22, 2021

SELL
$161.5 - $179.47 $130,492 - $145,011
-808 Reduced 5.18%
14,783 $2.39 Million
Q4 2020

Feb 26, 2021

SELL
$137.11 - $157.38 $122,165 - $140,225
-891 Reduced 5.41%
15,591 $2.45 Million
Q3 2020

Nov 12, 2020

BUY
$140.38 - $153.83 $91,948 - $100,758
655 Added 4.14%
16,482 $2.4 Million
Q3 2020

Nov 12, 2020

SELL
$140.38 - $153.83 $70,190 - $76,915
-500 Reduced 3.06%
15,827 $2.36 Million
Q2 2020

Aug 18, 2020

SELL
$128.81 - $155.51 $19,965 - $24,104
-155 Reduced 0.94%
16,327 $2.3 Million
Q4 2019

Feb 11, 2020

SELL
$127.5 - $146.44 $100,087 - $114,955
-785 Reduced 4.55%
16,482 $2.4 Million
Q3 2019

Nov 15, 2019

SELL
$126.95 - $142.14 $27,548 - $30,844
-217 Reduced 1.24%
17,267 $2.23 Million
Q2 2019

Aug 14, 2019

SELL
$131.15 - $144.24 $52,328 - $57,551
-399 Reduced 2.23%
17,484 $2.44 Million
Q1 2019

May 14, 2019

SELL
$125.72 - $139.79 $1.6 Million - $1.78 Million
-12,700 Reduced 41.53%
17,883 $2.5 Million
Q4 2018

Feb 13, 2019

SELL
$122.84 - $147.84 $810,744 - $975,744
-6,600 Reduced 17.75%
30,583 $3.95 Million
Q3 2018

Nov 14, 2018

SELL
$121.58 - $142.88 $145,896 - $171,456
-1,200 Reduced 3.13%
37,183 $5.14 Million
Q2 2018

Aug 10, 2018

SELL
$119.4 - $131.76 $143,280 - $158,112
-1,200 Reduced 3.03%
38,383 $4.66 Million
Q1 2018

May 17, 2018

SELL
$125.1 - $148.14 $280,224 - $331,833
-2,240 Reduced 5.36%
39,583 $5.07 Million
Q4 2017

Feb 15, 2018

SELL
$131.22 - $143.62 $295,245 - $323,145
-2,250 Reduced 5.11%
41,823 $5.84 Million
Q3 2017

Nov 13, 2017

BUY
$129.47 - $135.38 $5.71 Million - $5.97 Million
44,073
44,073 $5.73 Million

Others Institutions Holding JNJ

About JOHNSON & JOHNSON


  • Ticker JNJ
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,614,479,872
  • Market Cap $379B
  • Description
  • Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...
More about JNJ
Track This Portfolio

Track Doheny Asset Management /Ca Portfolio

Follow Doheny Asset Management /Ca and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Doheny Asset Management /Ca, based on Form 13F filings with the SEC.

News

Stay updated on Doheny Asset Management /Ca with notifications on news.